Literature DB >> 34131032

Subregion-Specific Regulation of Dopamine D1 Receptor Signaling in the Striatum: Implication for L-DOPA-Induced Dyskinesia.

Keita Sugiyama1, Mahomi Kuroiwa1, Takahide Shuto1, Yoshinori N Ohnishi1, Yukie Kawahara1, Yuta Miyamoto2, Takaichi Fukuda2, Akinori Nishi3.   

Abstract

The striatum is the main structure of the basal ganglia. The striatum receives inputs from various cortical areas, and its subregions play distinct roles in motor and emotional functions. Recently, striatal maps based on corticostriatal connectivity and striosome-matrix compartmentalization were developed, and we were able to subdivide the striatum into seven subregions. Dopaminergic modulation of the excitability of medium spiny neurons (MSNs) is critical for striatal function. In this study, we investigated the functional properties of dopamine signaling in seven subregions of the striatum from male mice. By monitoring the phosphorylation of PKA substrates including DARPP-32 in mouse striatal slices, we identified two subregions with low D1 receptor signaling: the dorsolateral portion of the intermediate/rostral part (DL-IR) and the intermediate/caudal part (IC). Low D1 receptor signaling in the two subregions was maintained by phosphodiesterase (PDE)10A and muscarinic M4 receptors. In an animal model of 6-hydroxydopamine (6-OHDA)-induced hemi-parkinsonism, D1 receptor signaling was upregulated in almost all subregions including the DL-IR, but not in the IC. When L-DOPA-induced dyskinesia (LID) was developed, D1 receptor signaling in the IC was upregulated and correlated with the severity of LID. Our results suggest that the function of the striatum is maintained through the subregion-specific regulation of dopamine D1 receptor signaling and that the aberrant activation of D1 receptor signaling in the IC is involved in LID. Future studies focusing on D1 receptor signaling in the IC of the striatum will facilitate the development of novel therapeutics for LID.SIGNIFICANCE STATEMENT Recent progress in striatal mapping based on corticostriatal connectivity and striosome-matrix compartmentalization allowed us to subdivide the striatum into seven subregions. Analyses of D1 receptor signaling in the seven subregions identified two unique subregions with low D1 receptor signaling: the dorsolateral portion of the intermediate/rostral part (DL-IR) and the intermediate/caudal part (IC). Aberrant activation of D1 receptor signaling in the IC is involved in L-DOPA-induced dyskinesia (LID). Previous studies of LID have mainly focused on the DL-IR, but not on the IC of the striatum. Future studies to clarify aberrant D1 receptor signaling in the IC are required to develop novel therapeutics for LID.
Copyright © 2021 the authors.

Entities:  

Keywords:  D1 receptor; DARPP-32; L-DOPA-induced dyskinesia; dopamine; striatum

Mesh:

Substances:

Year:  2021        PMID: 34131032      PMCID: PMC8318081          DOI: 10.1523/JNEUROSCI.0373-21.2021

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  54 in total

1.  Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation.

Authors:  Sarah Threlfell; Stephen Sammut; Frank S Menniti; Christopher J Schmidt; Anthony R West
Journal:  J Pharmacol Exp Ther       Date:  2008-12-04       Impact factor: 4.030

Review 2.  An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors.

Authors:  S Ferré; C Quiroz; A S Woods; R Cunha; P Popoli; F Ciruela; C Lluis; R Franco; K Azdad; S N Schiffmann
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

3.  Are striatal tyrosine hydroxylase interneurons dopaminergic?

Authors:  Harry S Xenias; Osvaldo Ibáñez-Sandoval; Tibor Koós; James M Tepper
Journal:  J Neurosci       Date:  2015-04-22       Impact factor: 6.167

4.  Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen.

Authors:  C C Ouimet; K C Langley-Gullion; P Greengard
Journal:  Brain Res       Date:  1998-10-12       Impact factor: 3.252

5.  Dense GABAergic input on somata of parvalbumin-immunoreactive GABAergic neurons in the hippocampus of the mouse.

Authors:  T Fukuda; Y Aika; C W Heizmann; T Kosaka
Journal:  Neurosci Res       Date:  1996-10       Impact factor: 3.304

6.  Cholinergic Interneurons Amplify Thalamostriatal Excitation of Striatal Indirect Pathway Neurons in Parkinson's Disease Models.

Authors:  Asami Tanimura; Yijuan Du; Jyothisri Kondapalli; David L Wokosin; D James Surmeier
Journal:  Neuron       Date:  2019-01-15       Impact factor: 17.173

7.  Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents.

Authors:  S M Hersch; B J Ciliax; C A Gutekunst; H D Rees; C J Heilman; K K Yung; J P Bolam; E Ince; H Yi; A I Levey
Journal:  J Neurosci       Date:  1995-07       Impact factor: 6.167

8.  Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats.

Authors:  Ippolita Cantuti-Castelvetri; Ledia F Hernandez; Christine E Keller-McGandy; Lauren R Kett; Alex Landy; Zane R Hollingsworth; Esen Saka; Jill R Crittenden; Eduardo A Nillni; Anne B Young; David G Standaert; Ann M Graybiel
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

9.  L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission.

Authors:  Michael Feyder; Alessandra Bonito-Oliva; Gilberto Fisone
Journal:  Front Behav Neurosci       Date:  2011-10-24       Impact factor: 3.558

10.  Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments.

Authors:  Jill R Crittenden; Ann M Graybiel
Journal:  Front Neuroanat       Date:  2011-09-07       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.